LAIR1 and B-cell chronic lymphocytic leukemia: Furthermore, LAIR1 markedly inhibits the constitutive and BCR-induced Akt activation as well as the nuclear translocation of NF-kB activation, preventing the proliferation of B CLL cells [44].